Skip to navigation Skip to main content
Oncology Nurse Advisor
  • Cancer Types
    • Cancer Types
      • Brain Cancer
      • Breast Cancer
      • Cervical Cancer
      • Chronic Myeloid Leukemia‎
      • Colorectal Cancer
      • Gastrointestinal Cancer
      • General Oncology
      • Genitourinary Cancer
      • Gynecologic Cancer
      • Head and Neck Cancer
      • Hematologic Cancers
      • Kidney Cancer
      • Leukemia
      • Liver Cancer
      • Lung Cancer
      • Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myeloproliferative Neoplasms
      • Ovarian Cancer
      • Pancreatic Cancer
      • Prostate Cancer
      • Sarcoma
      • Skin Cancer
  • Hot Topics
    • Hot Topics
      • Advisor Forum
      • Ask a Pharmacist
      • Ask the Experts
      • Communication Challenges
      • Complementary and Alternative Medicine
      • From CancerCare
      • General Medicine
      • Issues in Cancer Survivorship
      • Journal Review
      • Navigation
      • Oncology Nursing
      • Radiation and Your Patient
      • Reflections
      • Side-Effect Management
      • Stat Consult
      • The Patient’s Voice
      • The Total Patient
  • Regimens
  • Resources
    • Resources

      Clinical Tools

      • Clinical Charts
      • Drug Information Database
      • Medical Calculators

      Professional Resources

      • Expert Perspective
      • Digital Issues
      • Job Board
      • Product Directory
      • Useful Links
  • For Patients
    • For Patients
      • Advocacy
      • Cancer Support Groups
      • Fact Sheets
      • Finding Clinical Trials
  • Conferences
    • Conferences

      Oncology Conferences

      • Conference Coverage

      News Resources

      • Daily Oncology News
      • Web Exclusives
  • ONA Summit
  • News
  • CE
  • Fact Sheets
  • Publishers Alliance
  • Navigation
  • Expert Perspective
  • Slideshows
  • Jobs

Home » Headlines

Publish Date October 14, 2015

Early Noninvasive Ventilation May Not Be Better for Patients With Acute Respiratory Failure

  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Reddit
  • Print
  • Share by Email

the Oncology Nurse Advisor take:

Among immunocompromised patients admitted to intensive care units (ICUs) with hypoxemic acute respiratory failure, early noninvasive ventilation did not reduce 28-day mortality compared with oxygen therapy alone, according to a new study published online ahead of print in JAMA.

Although noninvasive ventilation has been recommended to decrease mortality among immunocompromised patients with hypoxemic acute respiratory failure, its effectiveness has remained unclear.

Therefore, researchers sought to evaluate whether early noninvasive ventilation improved survival in these patients.

For the multicenter trial, researchers enrolled 374 critically ill immunocompromised patients at 28 ICUs in France and Belgium.

Of those, nearly 85% were receiving treatment for hematologic malignancies and solid tumors. Participants were randomly assigned to receive early noninvasive ventilation or oxygen therapy alone.

Results showed that at 28 days after randomization, 46 deaths had occurred in the noninvasive ventilation group compared with 50 in the oxygen group (P=0.47). In addition, oxygenation failure occurred in 73 patients and 82 patients, respectively (P=0.20).

Researchers found no significant differences in ICU-acquired infections, duration of mechanical ventilation, or lengths of ICU or hospital stays between the two treatment arms.

The authors note that the study power was limited and this may affect the applicability of the findings.

Early noninvasive ventilation did not reduce 28-day mortality compared with oxygen therapy alone.

Corresponding Author: Elie Azoulay, MD, PhD, Medical Intensive Care Unit, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France ( [email protected]). Published Online: October 7, 2015. doi: 10.1001/jama.2015.12402. Author Contributions: Drs Lemiale and Resche-Rigon had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

READ FULL ARTICLE Curated publisher From Jamanetwork

Topics:

Cancer
  • Loading...

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next post in Headlines
Recreational use of this fast-acting drug can be fatal

Study Assesses Epidemiology of Carbapenem-resistant Enterobacteriaceae

Back to Top
  • Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community online and in print. Daily online exclusives cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect management, and new developments in specific cancers.

  • Resources
    • Editorial Board
    • Subscribe
    • Author Guidelines
    • Permissions
    • Reprints
  • User Center
    • About Us
    • Contact Us
    • Advertise
  • Other Haymarket Medical Websites
    • Cancer Therapy Advisor
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • McKnight’s Long Term Care News
    • McKnight’s Senior Living
    • Medical Bag
    • MPR
    • myCME
    • Neurology Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
  • Copyright © 2023 Haymarket Media, Inc. All Rights Reserved
    This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
    Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

Loading...
Loading...
Loading...
Loading...